私たちは何十年もの間、あらゆる病気を治すと約束してきた。最新：21億ドルとノーベル賞
私たちは何十年もの間、あらゆる病気を治すと約束してきた。最新の動きとして、あるバイオテクノロジー企業が21億ドルの資金調達に成功し、その創設者がノーベル賞を受賞。しかし、こうした壮大な約束には過去に何度も失望させられてきた歴史があり、今回のプロジェクトが本当に異なるのかを考察する。
関連記事
Eric Topol highlights remarkable progress in cancer immunotherapy, noting that vaccines are now achieving cures or remissions in some of the most refractory cancers, including pancreatic, melanoma, glioblastoma, renal, and triple-negative breast cancer.
Colorectal cancer rates are increasing among younger adults, but the article urges caution in interpreting the trend, noting that absolute risk remains low and that the rise is partly due to improved detection and screening practices.
A new episode of Hard Drugs features Katharine Collins, who co-invented the R21 malaria vaccine during her PhD at Oxford's Jenner Institute. By modifying the expired patent of the first malaria vaccine (RTS,S), she created a cheaper, more scalable vaccine with a higher proportion of malaria antigen, making it more accessible for children worldwide.